日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Saccharomyces cerevisiae Malate dehydrogenase, peroxisomal (MDH3) CSB-YP327132SVG
CSB-EP327132SVG
CSB-BP327132SVG
CSB-MP327132SVG
CSB-EP327132SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Zinc finger protein SFP1 (SFP1), partial CSB-YP327133SVG
CSB-EP327133SVG
CSB-BP327133SVG
CSB-MP327133SVG
CSB-EP327133SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Histone chaperone ASF1 (ASF1) CSB-YP327134SVG
CSB-EP327134SVG
CSB-BP327134SVG
CSB-MP327134SVG
CSB-EP327134SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Protein HYM1 (HYM1) CSB-YP327135SVG
CSB-EP327135SVG
CSB-BP327135SVG
CSB-MP327135SVG
CSB-EP327135SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Protein HIR1 (HIR1), partial CSB-YP327136SVG
CSB-EP327136SVG
CSB-BP327136SVG
CSB-MP327136SVG
CSB-EP327136SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Increasing suppression factor 1 (ISF1) CSB-YP327137SVG
CSB-EP327137SVG
CSB-BP327137SVG
CSB-MP327137SVG
CSB-EP327137SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Centromere DNA-binding protein complex CBF3 subunit A (CBF2), partial CSB-YP327138SVG
CSB-EP327138SVG
CSB-BP327138SVG
CSB-MP327138SVG
CSB-EP327138SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant African swine fever virus Inner membrane protein p12, partial CSB-YP327139AEJ1
CSB-EP327139AEJ1
CSB-BP327139AEJ1
CSB-MP327139AEJ1
CSB-EP327139AEJ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Treponema hyodysenteriae Flagellar filament outer layer protein flaA1 (flaA1) CSB-YP327140TPQ
CSB-EP327140TPQ
CSB-BP327140TPQ
CSB-MP327140TPQ
CSB-EP327140TPQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human parainfluenza 1 virus Phosphoprotein (P/C), partial CSB-YP327141HOU
CSB-EP327141HOU
CSB-BP327141HOU
CSB-MP327141HOU
CSB-EP327141HOU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human enterovirus 70 Genome polyprotein CSB-YP327142HJB
CSB-EP327142HJB
CSB-BP327142HJB
CSB-MP327142HJB
CSB-EP327142HJB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Equine infectious anemia virus Protein Tat (tat) CSB-YP327143EFT
CSB-EP327143EFT
CSB-BP327143EFT
CSB-MP327143EFT
CSB-EP327143EFT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloarcula marismortui 30S ribosomal protein S7P (rps7p) CSB-YP327144HTJ
CSB-EP327144HTJ
CSB-BP327144HTJ
CSB-MP327144HTJ
CSB-EP327144HTJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Protein SCM4 (SCM4), partial CSB-YP327145SVG1
CSB-EP327145SVG1
CSB-BP327145SVG1
CSB-MP327145SVG1
CSB-EP327145SVG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Passionfruit woodiness virus Genome polyprotein CSB-YP327146PDG
CSB-EP327146PDG
CSB-BP327146PDG
CSB-MP327146PDG
CSB-EP327146PDG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae tRNA threonylcarbamoyladenosine biosynthesis protein SUA5 (SUA5) CSB-YP327147SVG
CSB-EP327147SVG
CSB-BP327147SVG
CSB-MP327147SVG
CSB-EP327147SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Tyrosine-protein phosphatase 3 (pyp3) CSB-YP327148SXV
CSB-EP327148SXV
CSB-BP327148SXV
CSB-MP327148SXV
CSB-EP327148SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine ephemeral fever virus Glycoprotein G (G), partial CSB-YP327149BJQ1
CSB-EP327149BJQ1
CSB-BP327149BJQ1
CSB-MP327149BJQ1
CSB-EP327149BJQ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Vacuolar segregation protein PEP7 (PEP7), partial CSB-YP327150SVG
CSB-EP327150SVG
CSB-BP327150SVG
CSB-MP327150SVG
CSB-EP327150SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Guanosine-diphosphatase (GDA1), partial CSB-YP327151SVG
CSB-EP327151SVG
CSB-BP327151SVG
CSB-MP327151SVG
CSB-EP327151SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×